Current Development on Surgical Treatment of Liver Cancer_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

吳孟超

Corresponding?author：

Keywords：

肝癌; 外科治療; 進展

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 吳孟超. Current Development on Surgical Treatment of Liver Cancer. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2006, 13(2): 125-128. doi: Copy

1.	ElSerag HB. Hepatocellular carcinoma: an epidemiologic view [Ｊ]. J Clin Gastroenterol, 2002; 35(5 Suppl 2)∶S72.
2.	Lok AS, McMahon BJ; Practice Cuidelines Committee, et al. Chronic hepatitis B: update of recommendations [Ｊ]. Hepatology， 2004; 39(3)∶857.
3.	Perrillo R, Hann HW, Mutimer D, et al. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus [Ｊ]. Gastroenterology， 2004; 126(1)∶81.
4.	Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma [Ｊ]. J Am Coll Surg， 2000; 191(4)∶381.
5.	Roayaie S, Frischer JS, Emre SH, et al. Longterm results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters [Ｊ]. Ann Surg， 2002; 235(4)∶533.
6.	吳孟超，陳漢，沈鋒. 原發性肝癌的外科治療——附5 524例報告 [Ｊ]. 中華外科雜志， 2001； 39（1）∶25.
7.	Yoo HY, Patt CH, Geschwind JF, et al. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5year survival has improved significantly with time [Ｊ]. J Clin Oncol， 2003; 21(23)∶4329.
8.	Schwartz JD, Schwartz M, Mandeli J, et al. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials [Ｊ]. Lancet Oncol， 2002; 3(10)∶593.

1. ElSerag HB. Hepatocellular carcinoma: an epidemiologic view [Ｊ]. J Clin Gastroenterol, 2002; 35(5 Suppl 2)∶S72.
2. Lok AS, McMahon BJ; Practice Cuidelines Committee, et al. Chronic hepatitis B: update of recommendations [Ｊ]. Hepatology， 2004; 39(3)∶857.
3. Perrillo R, Hann HW, Mutimer D, et al. Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus [Ｊ]. Gastroenterology， 2004; 126(1)∶81.
4. Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma [Ｊ]. J Am Coll Surg， 2000; 191(4)∶381.
5. Roayaie S, Frischer JS, Emre SH, et al. Longterm results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters [Ｊ]. Ann Surg， 2002; 235(4)∶533.
6. 吳孟超，陳漢，沈鋒. 原發性肝癌的外科治療——附5 524例報告 [Ｊ]. 中華外科雜志， 2001； 39（1）∶25.
7. Yoo HY, Patt CH, Geschwind JF, et al. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5year survival has improved significantly with time [Ｊ]. J Clin Oncol， 2003; 21(23)∶4329.
8. Schwartz JD, Schwartz M, Mandeli J, et al. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials [Ｊ]. Lancet Oncol， 2002; 3(10)∶593.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Current Development on Surgical Treatment of Liver Cancer

Abstract Full text Figures/Tables Video References Cited by

Format

Content